Psoriasis

The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.

Latest News

Psoriasis concept on skin of color | Image credit: CandyRetriever - stock.adobe.com
VISIBLE Trial Advances Diversity in Psoriasis Research

December 11th 2024

Novel strategies in the VISIBLE trial set a new standard for recruiting and retaining diverse participants with skin of color in dermatology clinical trials.

Psoriasis | image credit: pimentos – stock.adobe.com
Patients With Higher Disease Burden, Lower HRQoL More Likely to Switch to Biologic Therapies

December 10th 2024

Plaque psoriasis | Image credit: ksu_ok - stock.adobe.com
Most Patients With Moderate to Severe Psoriasis Continue Secukinumab Treatment

December 4th 2024

Cleansing vessels and veins from cholesterol. | Image credit: Kudryavtsev - stock.adobe.com
Psoriasis Risk Linked to Elevated Non-HDL to HDL Cholesterol Ratio, Study Finds

November 19th 2024

Image credit: Nitr - stock.adobe.com
Dried Fruit Intake Linked to Benefits in Psoriasis Treatment

November 12th 2024

A Personalized Approach to Disease Management in Psoriasis

A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.

Ryan Haumschild, PharmD, MS, MBA, Bhavesh Shah, PharmD, Mark Lebwohl, MD, and Robert Groves, MD.
Continuing Medical Education
View All
December 13th 2024

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
December 13th 2024

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology

More News

Elderly man suffering from psoriasis on hands | and.one - stock.adobe.com
February 12th 2024

Risankizumab Shown Effective With No Increase in Adverse Events vs Placebo in PsA

Pearl Steinzor
Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis.
psoriatic arthritis hand illustration | vectorwin - stock.adobe.com
February 7th 2024

Patients With Active Psoriatic Arthritis Achieve Continuous Disease Improvement With Guselkumab

Pearl Steinzor
Continuous improvement was observed across the different domains of minimal disease activity criteria with guselkumab.
Woman with scalp itch | Small fish - stock.adobe.com
January 22nd 2024

Guselkumab Demonstrates Significant Improvements in People of Color With Scalp Psoriasis

Pearl Steinzor
People of color with scalp psoriasis experienced significant improvement in scalp itch and patient-reported health-related quality-of-life outcomes.
Woman with psoriasis | Image credit: Andrey Popov - stock.adobe.com
January 17th 2024

Psoriasis Linked to Metabolic Disorders in Adult Patients, Study Finds

Pearl Steinzor
Physicians should be vigilant when managing patients with psoriasis and concurrent metabolic disorders, according to a new study.
Dermatological skin disease. psoriasis, eczema, dermatitis, allergies. Skin lesions on the head. | Егор Кулинич - stock.adobe.com
January 10th 2024

Deucravacitinib Shows Superior Efficacy Over Placebo, Apremilast in Patients With Moderate to Severe Scalp Psoriasis

Pearl Steinzor
Response rates were greater with deucravacitinib vs placebo or apremilast at 16 weeks in patients with moderate to severe scalp psoriasis, according to one study.
A man applies topical cream to plaque psoriasis patch on arm | Olga - stock.adobe.com
January 4th 2024

Topical PF-07038124 Demonstrates Superior Efficacy in Patients With AD, Plaque Psoriasis

Pearl Steinzor
A topical therapy, PF-07038124 0.01%, administered once daily was more effective than the vehicle control in patients with atopic dermatitis (AD) and plaque psoriasis, a study finds.
Top 5 Most-Read Psoriasis Content of 2023
December 30th 2023

Top 5 Most-Read Psoriasis Content of 2023

Pearl Steinzor
The top psoriasis articles included topics on new therapies for the treatment of psoriasis in adults.
A dermatologist wearing gloves examines the skin of a sick patient. Examination and diagnosis of skin diseases-allergies, psoriasis, eczema, dermatitis | Image credit: fusssergei - stock.adobe.com
December 29th 2023

Psoriasis Treatment Center of New Jersey Reports Positive Results for Tapinarof in Psoriasis Trial

Lauren Buchanan, MA
In this study, 52% of adult patients achieved the treat-to-target goal of 1% BSA or less within 3 months of incorporating tapinarof cream into their biologic regimen.
Allergy symptoms. Woman scratching her arm | Dragana Gordic - stock.adobe.com
December 18th 2023

More Images of Patients With Psoriasis Are Needed in Published Studies

Pearl Steinzor
Most studies involving the treatment of psoriasis do not contain any images of patients, a review finds.
Young woman suffering from itching on her skin and scratching an itchy place | Goffkein - stock.adobe.com
December 12th 2023

High Levels of Cholesterol, Low-Density Lipoprotein Cholesterol, Among Genetic Risk Factors for Psoriasis

Emma Andrus
Investigators explored the genetic relationship between psoriatic disease and serum lipid levels.
Allergic reaction, itch, allergy, dermatiti concept. | DimaBerlin - stoc.adobe.com
December 5th 2023

Clinical Characteristics, Outcomes of Patients With Plaque Psoriasis on Tapinarof Cream

Pearl Steinzor
Two posters presented at the 2023 Fall Clinical Dermatology Conference examined patient demographics, clinical characteristics, and outcomes in patients with plaque psoriasis treated with tapinarof cream.
Psoriasis skin, eczema, rash and other skin diseases. A woman hides her face, she is ashamed of her autoimmune genetic disease. Imperfect beauty. | Image credit: stockmaster - stock.adobe.com.jpg
November 30th 2023

Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available

Denise Myshko
Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.
depressed woman | Image credit: Stanislaw Mikulski - stock.adobe.com
November 24th 2023

Study Finds Link Between Depression, Functional Impairment in Psoriasis, Psoriatic Arthritis

Skylar Jeremias
Depression symptoms are often underdiagnosed and undertreated in patients with psoriasis and psoriatic arthritis, contributing to a worsened quality of life (QOL). However, a recent study found that depression, functional impairment, and worsened QOL are related.
Psoriasis skin. Closeup of rash and scaling on the patient's skin. The concept of chronic disease treatment. Dermatological problems | IIIRusya - stock.adobe.com
November 13th 2023

Evaluating Work Productivity, Efficacy and Safety of Tildrakizumab in Patients With Plaque Psoriasis

Pearl Steinzor
Two posters presented at the 2023 Fall Clinical Dermatology Conference assessed phase 4 study findings on tildrakizumab in patients with moderate to severe plaque psoriasis.
A dermatologist wearing gloves examines the skin of a sick patient. Examination and diagnosis of skin diseases-allergies, psoriasis, eczema, dermatitis | Image credit: fusssergei - stock.adobe.com
November 9th 2023

Evaluating Label Warnings, Switching Rates in Patients With Psoriasis Initiating New Treatment

Pearl Steinzor
Posters presented at the 2023 Fall Clinical Dermatology Conference evaluated how label warnings may affect new treatment initiation and real-word switching patterns for patients starting risankizumab.
Elderly man suffering from psoriasis on hands | and.one - stock.adobe.com
November 2nd 2023

Real-World Management, Treatment Patterns in Patients With Psoriasis, Psoriatic Arthritis

Pearl Steinzor
Two posters presented at the 2023 Fall Clinical Dermatology conference identified common patterns among patients with psoriasis (PsO) and psoriatic arthritis (PsA).
Dermatology consultation woman | RFBSIP - stock.adobe.com
October 31st 2023

Psoriasis Not Linked to Spontaneous Mutations in Skin Cells, Study Finds

Pearl Steinzor
No genes were identified in psoriatic patches that were not also mutated in the patient’s unaffected skin area.
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
October 26th 2023

Dr Mona Shahriari Discusses Treatment of Plaque Psoriasis in Patients With Skin of Color

Hayden E. Klein Pearl Steinzor
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, provides on overview of the treatment landscape in patients with skin of color with plaque psoriasis.
Psoriasis skin. Psoriasis is an autoimmune disease that affects the skin cause skin inflammation red and scaly | КРИСТИНА Игумнова - stock.adobe.com
October 26th 2023

Understanding Biologic Therapy Switching Patterns in Psoriasis and Psoriatic Arthritis Patients

Lauren Buchanan, MA
This study aimed to evaluate the association between the disease burden of psoriasis and the switching of systemic biologic therapies in patients with both psoriasis and psoriatic arthritis.
A dermatologist wearing gloves examines the skin of a sick patient. Examination and diagnosis of skin diseases-allergies, psoriasis, eczema, dermatitis | Image credit: fusssergei - stock.adobe.com
October 23rd 2023

Patients With Mild Psoriasis Face Less Favorable Status at Diagnosis, First Line of Treatment, Study Finds

Pearl Steinzor
Psoriasis status from time of diagnosis to initiation of current treatment was less favorable for patients with mild psoriasis compared with moderate psoriasis, according to one study.
dark hand of a worker with b calluses protests. Stop | vovan - stock.adobe.com
October 12th 2023

Black, Male Children Have Increased Risk of Palmoplantar Psoriasis, Study Finds

Pearl Steinzor
Compared with White patients, Black male patients had a higher prevalence of palmoplantar psoriasis, according to one study.
Delayed rubber stamp | Image credit: lkeskinen - stock.adobe.com
September 30th 2023

FDA Delays UCB’s Bimekizumab Approval

Kaitlyn Bader
FDA action is no longer expected in Q3 of 2023.
woman checking her skin for an abnormal mole for signs of melanoma skin cancer | Image credit: MW Photography - stock.adobe.com
September 27th 2023

Study Identifies a Causal Relationship Between Psoriasis and Cutaneous Melanoma

Pearl Steinzor
Psoriasis increases the risk of cutaneous melanoma, according to the findings of a new study.
Psoriasis skin, eczema, rash and other skin diseases. A woman hides her face, she is ashamed of her autoimmune genetic disease. Imperfect beauty. | Image credit: stockmaster - stock.adobe.com
September 20th 2023

Patients With Severe Psoriasis Have Higher Risk of Heart Disease, Study Says

Pearl Steinzor
Decreased coronary flow was associated with severe psoriasis, according to one study.
psoriatic arthritis | Image credit: Iri-s - stock.adobe.com
September 14th 2023

Clinical Specialization Impacts Treatment in Psoriatic Arthritis

Heather Raglin
Patients treated by rheumatologists were more often treated with tumor necrosis factor inhibitors, according to one study.
Telehealth with laptop, tablet, and stethoscope | Image credit: NIKCOA - stock.adobe.com
September 12th 2023

Patients With Psoriasis, Psoriatic Arthritis Had Similar Adherence to Apremilast by Telehealth or In-Person Visit

Pearl Steinzor
Telehealth visits were just as effective as in-person visits at managing patients initiating apremilast.
Psoriasis | image credit: pimentos – stock.adobe.com
September 7th 2023

Psoriasis Linked to Lower Fertility Rate, Increased Risk of Pregnancy Loss

Pearl Steinzor
Lower fertility rate and increased risk of pregnancy loss were identified among women with moderate to severe psoriasis, according to a new study.
psoriasis-itch
August 28th 2023

Differing Views on Disease Severity Linked to Worse Symptoms, QOL in Psoriasis, Eczema

Pearl Steinzor
Patients and physicians often disagree on the patient’s disease severity, creating a relationship barrier and frustration among both parties.
Vitamin D - Sonne: © ExQuisine - stock.adobe.com
August 23rd 2023

NHANES Data Portray Potential Link Between Psoriasis Severity, Vitamin D

Peter Page
The most severe psoriasis was associated with the lowest blood levels of vitamin D and the greatest affected body surface area.
Image of patients of different races.jpe
August 16th 2023

Race Not Independently Associated With Biologic Access for Psoriasis in the United States

Pearl Steinzor
No significant differences regarding racial backgrounds were found when measuring access to biologics among adult patients with psoriasis living in the United States, according to one study.
<12345678
...
14>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo